Concepedia

Natalie Brajanovski

NB

Statistics

Publications

8

Citations

713

H-Index

8

Active since

2015

Affiliations

Peter MacCallum Cancer Centre(Current)

The University of Melbourne

Monash University

St Vincent's Hospital Melbourne

The University of Queensland

Natalie Brajanovski is an author at Peter MacCallum Cancer Centre specializing in tumor biology, medicine, and cancer research.

ORCID

Top concepts

Publications per year

2015–2024

8

Publications

8

CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer

Elaine Sanij, Katherine M. Hannan, Jiachen Xuan et al. · Nature Communications · 2020 · 213 citations · Full text

First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation Study

Amit Khot, Natalie Brajanovski, Donald P. Cameron et al. · Cancer Discovery · 2019 · 197 citations

Regulation of PRMT5–MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma

Shatha AbuHammad, Carleen Cullinane, Claire Martin et al. · Proceedings of the National Academy of Sciences · 2019 · 116 citations · Full text

, , +17

Palbociclib synergizes with BRAF and MEK inhibitors in treatment naïve melanoma but not after the development of BRAF inhibitor resistance

Claire Martin, Carleen Cullinane, Laura Kirby et al. · International Journal of Cancer · 2017 · 72 citations

, , +15

Changes in long-range rDNA-genomic interactions associate with altered RNA polymerase II gene programs during malignant transformation

Jeannine Diesch, Megan J. Bywater, Elaine Sanij et al. · Communications Biology · 2019 · 46 citations · Full text

Rows per page

1–5 of 8